Form 4: UTI Legal Officer Sells Shares Under 10b5-1 Plan

Universal Technical Institute's EVP and Chief Legal Officer, Christopher E. Kevane, sold 23,654 shares of common stock.

Summary

• Christopher E. Kevane, the Executive Vice President and Chief Legal Officer of Universal Technical Institute Inc. (UTI), disposed of 23,654 shares of the company's common stock.
• The transaction occurred on March 27, 2026, at a weighted average price of $37.5461 per share, with prices ranging from $37.16 to $37.79.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• Following this transaction, Mr. Kevane beneficially owns 83,521 shares of UTI common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal due to the insider sale, though the impact is mitigated by the transaction being part of a Rule 10b5-1 plan.

Negatives

• An executive officer sold a significant number of shares (23,654 shares), reducing their direct ownership in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when conducted under pre-arranged 10b5-1 plans, are routinely monitored by investors for potential insights into management's perspective on future company performance. This specific transaction by a Chief Legal Officer is a standard disclosure for a publicly traded educational services company like Universal Technical Institute.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a slight negative signal, potentially impacting investor sentiment.

Key Dates

Recommendation

The sale by the EVP and Chief Legal Officer, while notable, was conducted under a pre-arranged 10b5-1 plan, which often indicates a planned liquidity event rather than a reaction to new negative information. Without additional context or other significant news, this single transaction does not warrant a strong buy or sell recommendation, suggesting a 'hold' position to observe further developments.

Keywords

Universal Technical Institute, UTI, Insider Trading, Form 4, Stock Sale, Christopher Kevane, Legal Officer, 10b5-1 Plan